| 1 |
Maccaroni E, Lunerti V, Agostinelli V, Giampieri R, Zepponi L, Pagliacci A, Berardi R. New Insights into Hormonal Therapies in Uterine Sarcomas. Cancers 2022;14:921. [DOI: 10.3390/cancers14040921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Chen J, Wang J, Cao D, Yang J, Huang H, Pan L, Xiang Y. Low-grade endometrial stromal sarcoma with intracaval or intracardiac extension: a retrospective study of eight cases. Arch Gynecol Obstet. [DOI: 10.1007/s00404-021-06373-4] [Reference Citation Analysis]
|
| 3 |
Cabrera S, Bebia V, Acosta U, Franco-Camps S, Mañalich L, García-Jiménez A, Gil-Moreno A. Survival outcomes and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma. Clin Transl Oncol 2021;23:1210-9. [PMID: 33210235 DOI: 10.1007/s12094-020-02512-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Maenohara S, Fujimoto T, Okadome M, Sonoda K, Taguchi K, Saito T. Potential alternative progestin therapy for low-grade endometrial stromal sarcoma: A case report. Gynecol Oncol Rep 2020;34:100634. [PMID: 32953963 DOI: 10.1016/j.gore.2020.100634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 5 |
Wu J, Zhang H, Li L, Hu M, Chen L, Wu S, Xu B, Song Q. Prognostic nomogram for predicting survival in patients with high grade endometrial stromal sarcoma: a Surveillance Epidemiology, and End Results database analysis. Int J Gynecol Cancer 2020;30:1520-7. [PMID: 32839227 DOI: 10.1136/ijgc-2020-001409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 6 |
Maeda O, Nagasaka T, Ito M, Mitsuishi T, Murakami F, Uematsu T, Hattori Y, Iwata H, Ogino H. Long-term multidisciplinary treatment including proton therapy for a recurrent low-grade endometrial stromal sarcoma and pathologically prominent epithelial differentiation: an autopsy case report. BMC Womens Health 2020;20:154. [PMID: 32711524 DOI: 10.1186/s12905-020-01019-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Gangireddy M, Chan Gomez J, Kanderi T, Joseph M, Kundoor V. Recurrence of Endometrial Stromal Sarcoma, Two Decades Post-Treatment. Cureus 2020;12:e9249. [PMID: 32821595 DOI: 10.7759/cureus.9249] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 8 |
Purbadi S, Saspriyana KY. Recurrent endometrial stromal sarcoma in the abdominal wall following a total hysterectomy: A rare case report. Int J Surg Case Rep 2020;68:242-5. [PMID: 32197223 DOI: 10.1016/j.ijscr.2020.03.003] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 9 |
Pannier D, Cordoba A, Ryckewaert T, Robin Y, Penel N. Hormonal therapies in uterine sarcomas, aggressive angiomyxoma, and desmoid-type fibromatosis. Critical Reviews in Oncology/Hematology 2019;143:62-6. [DOI: 10.1016/j.critrevonc.2019.08.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 10 |
Cui R, Cao G, Bai H, Zhang Z. The clinical benefits of hormonal treatment for LG-ESS: a meta-analysis. Arch Gynecol Obstet. 2019;300:1167-1175. [PMID: 31583462 DOI: 10.1007/s00404-019-05308-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 11 |
Wu H, Luo Y, Yin N, Gui W, Cao Y. Vaginal endometrial stromal sarcoma: A literature review. Eur J Obstet Gynecol Reprod Biol X 2019;4:100094. [PMID: 31528854 DOI: 10.1016/j.eurox.2019.100094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 12 |
Zang Y, Dong M, Zhang K, Gao C, Guo F, Wang Y, Xue F. Hormonal therapy in uterine sarcomas. Cancer Med 2019;8:1339-49. [PMID: 30897294 DOI: 10.1002/cam4.2044] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 13 |
Kanao H, Hisa T, Omi M, Nagashima M, Okamoto S, Aoki Y, Tanigawa T, Matoda M, Okamoto S, Nomura H, Omatsu K, Kato K, Utsugi K, Takeshima N. Laparoscopic Anterior Pelvic Exenteration with Super Radical Parametrectomy for a Recurrent Low-Grade Endometrial Sarcoma That is Resistant to Hormone Therapy and Chemotherapy. Journal of Minimally Invasive Gynecology 2019;26:34-5. [DOI: 10.1016/j.jmig.2018.03.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 14 |
Baek MH, Park JY, Park Y, Kim KR, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH. Androgen receptor as a prognostic biomarker and therapeutic target in uterine leiomyosarcoma. J Gynecol Oncol 2018;29:e30. [PMID: 29533018 DOI: 10.3802/jgo.2018.29.e30] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 15 |
Ricci S, Rubinsak L, Temkin SM. Uterine Sarcoma: Modern Treatment Paradigms. Curr Obstet Gynecol Rep 2017;6:290-297. [DOI: 10.1007/s13669-017-0227-x] [Reference Citation Analysis]
|
| 16 |
Cui R, Yuan F, Wang Y, Li X, Zhang Z, Bai H. Clinicopathological characteristics and treatment strategies for patients with low-grade endometrial stromal sarcoma. Medicine (Baltimore). 2017;96:e6584. [PMID: 28403089 DOI: 10.1097/md.0000000000006584] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 17 |
Fadeeva EP, Lisyanskaya AS, Manikhas GM, Glushakov RI, Tapilskaya NI. Aromatase inhibitors of the third generation in endocrine therapy of breast cancer and endometrial cancer: the successes and failures of the combination therapy. Rev Clin Pharm Drug Ther 2016;14:47-57. [DOI: 10.17816/rcf14247-57] [Reference Citation Analysis]
|
| 18 |
Maeda O, Moritani S, Ichihara S, Inoue T, Ishihara Y, Yamamoto S, Ito M, Matsumura Y, Sugiyama K, Horio M, Kondo I. Long-term survival in low-grade endometrial stromal sarcoma with childbirth and multidisciplinary treatment: a case report. J Med Case Rep. 2015;9:233. [PMID: 26481040 DOI: 10.1186/s13256-015-0719-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
